Asset Dedication’s NanoViricides NNVC Stock Holding History
Bought
Maintained
Sold
Other funds holding NNVC
Asset Dedication's NNVC Position: Q3 2026 in Review
Asset Dedication held its NanoViricides (NNVC) position steady in Q3 2026 at 1,450 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.
Asset Dedication first reported a position in NNVC in Q3 2022 and has held it in 17 quarters since. The position peaked at $3K in Q3 2022. 38 funds tracked by Wall St. Rank hold NNVC as of Q3 2026.
- Asset Dedication held 1,450 shares of NanoViricides worth $1.88K as of Q3 2026.
- Asset Dedication left its NanoViricides share count unchanged in Q3 2026.
- NanoViricides made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #1025 holding.
- Asset Dedication first reported a position in NanoViricides in Q3 2022 and has held it in 17 quarters since.
- Asset Dedication's NanoViricides position peaked at $3K in Q3 2022.
- 38 funds tracked by Wall St. Rank held NanoViricides as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.